ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moodley, Y.
Right arrow Articles by Lalloo, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moodley, Y.
Right arrow Articles by Lalloo, U.
Eur Respir J 1999; 14: 822-827
Copyright © ERS Journals Ltd 1999

Original Articles

Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis

YP Moodley, R Chetty, and UG Lalloo

Cytokines such as tumour necrosis factor-alpha and interferon gamma are associated with active pulmonary inflammation in sarcoidosis and they upregulate inducible nitric oxide synthase (iNOS). The objectives of this study were to examine iNOS upregulation in sarcoidosis by showing raised exhaled nitric oxide and increased iNOS activity in lung biopsy specimens of these patients utilizing immunohistochemistry. Exhaled NO was measured by a chemiluminescence analyser in 12 patients with newly diagnosed biopsy-proven sarcoidosis before and after 6 weeks of corticosteroid therapy. Lung biopsy specimens from these patients were subjected to immunohistochemical staining with a specific iNOS antibody. Exhaled NO was raised in newly diagnosed sarcoidosis (mean+/-SEM): 9.8+/-0.4 versus 4.1+/-0.2 parts per billion (ppb) in 21 healthy controls, p<0.001; and fell significantly after 6 weeks treatment with corticosteroids to 5.9+/-1.4 ppb; p<0.01. There was no correlation between exhaled NO and other markers of disease activity. Immunohistochemical staining demonstrated iNOS activity in respiratory epithelium and granulomas in patients with sarcoidosis. Exhaled nitric oxide is raised in patients with active pulmonary sarcoidosis and may be a result of inducible nitric oxide synthase upregulation. The fall in exhaled nitric oxide following corticosteroid therapy may reflect inhibition of inducible nitric oxide synthase in the respiratory epithelium and granulomas.


This article has been cited by other articles:


Home page
 ThoraxHome page
D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste
Exhaled nitric oxide measurements: clinical application and interpretation
Thorax, September 1, 2006; 61(9): 817 - 827.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
Y. Komohara, J. Hirahara, T. Horikawa, K. Kawamura, E. Kiyota, N. Sakashita, N. Araki, and M. Takeya
AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype
J. Histochem. Cytochem., July 1, 2006; 54(7): 763 - 771.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M L Wilsher, W Fergusson, D Milne, and A U Wells
Exhaled nitric oxide in sarcoidosis
Thorax, November 1, 2005; 60(11): 967 - 970.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Ziora, K. Kaluska, and J. Kozielski
An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Eur. Respir. J., October 1, 2004; 24(4): 609 - 614.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. D. Lang, P. J. McArdle, P. J. O'Reilly, and S. Matalon
Oxidant-Antioxidant Balance in Acute Lung Injury
Chest, December 1, 2002; 122 (2009): 314S - 320S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D.V. Pechkovsky, G. Zissel, C. Stamme, T. Goldmann, H. Ari Jaffe, M. Einhaus, C. Taube, H. Magnussen, M. Schlaak, and J. Muller-Quernheim
Human alveolar epithelial cells induce nitric oxide synthase-2 expression in alveolar macrophages
Eur. Respir. J., April 1, 2002; 19(4): 672 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. A. KHARITONOV and P. J. BARNES
Exhaled Markers of Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.